# Safety and Efficacy of Long-term Somatropin Treatment in Adults

> **NCT01543880** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 752 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT01543880
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2013-12
- **Final completion:** 2014-06
- **Target enrollment:** 752 (ACTUAL)
- **Last updated:** 2015-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543880, "Safety and Efficacy of Long-term Somatropin Treatment in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01543880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*